Decreasing variation in the use of hospice among older adults with breast, colorectal, lung, and prostate cancer

Medical Care

Volumn 42, Issue 2, 2004, Pages 116-122

  Lackan, Nuha A ^a   Ostir, Glenn V ^a,b   Freeman, Jean L ^a,b   Mahnken, Jonathan D ^a   Goodwin, James S ^a,b  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Aging; Cancer; Hospice; Variation

Indexed keywords

AGED; ARTICLE; BREAST TUMOR; COLORECTAL TUMOR; EPIDEMIOLOGY; FEMALE; HOSPICE CARE; HUMAN; INSURANCE; LENGTH OF STAY; LUNG TUMOR; MALE; MEDICARE; PROSTATE TUMOR; RACE; RISK; RURAL POPULATION; SOCIOECONOMICS; STATISTICAL MODEL; STATISTICS; UNITED STATES; URBAN POPULATION; UTILIZATION REVIEW;

AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; COLORECTAL NEOPLASMS; CONTINENTAL POPULATION GROUPS; FEMALE; HEALTH CARE SURVEYS; HOSPICE CARE; HUMANS; INSURANCE COVERAGE; LENGTH OF STAY; LOGISTIC MODELS; LUNG NEOPLASMS; MALE; MEDICARE; ODDS RATIO; PROSTATIC NEOPLASMS; RURAL POPULATION; SOCIOECONOMIC FACTORS; UNITED STATES; URBAN POPULATION;

EID: 1442303996     PISSN: 00257079     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mlr.0000108765.86294.1b     Document Type: Article

References (29)

1. Cassel CK, Field MJ, eds. Approaching Death: Improving Care at the End of Life. Washington, DC: National Academy Press; 1997.
2. Facts and Figures on Hospice Care in America. [National Hospice and Palliative Care Organization web site.] Available at: http://www.nhpco.org. Accessed January 10, 2003.
3. Lackan NA, Freeman JL, Goodwin JS. Hospice use by older women dying with breast cancer between 1991 and 1996. J Palliat Care. 2003;19:49-53.
4. Medicare: More Beneficiaries Use Hospice But for Fewer Days of Care. GAO/HEHS-00-182, Washington, DC: US General Accounting Office; September 18, 2000.
5. Greer AL. The state of the art versus the state of the science. The diffusion of new medical technologies into practice. Int J Technol Assess Health Care. 1988;4:5-26.
6. Oldenburg B, Hardcastle DM, Kok G. Diffusion of innovations. In: Glanz, K, Lewis FM, Rimer BK, eds. Health Behavior and Health Education. San Francisco: Jossey-Bass Publishers; 1997:270-286.
7. Greer AL. Advances in the study of diffusion of innovation in health care organizations. Milbank Memorial Fund Quarterly: Health and Society. 1977;55:505-532.
8. Rogers EM. Diffusion of Innovations. New York: The Free Press; 1995.
9. Nattinger AB, Gottlieb MS, Veum J, et al. Geographic variation in the use of breast-conserving treatment for breast cancer. N Engl J Med. 1992;326:1102-1107.
10. Virnig BA, Morgan RO, Persily NA, et al. Racial and income differences in use of the hospice benefit between the Medicare managed care and Medicare fee-for-service. J Palliat Med. 1999;2:23-31.
11. Virnig BA, Persily NA, Morgan RO, et al. Do Medicare HMOs and Medicare FFS differ in their use of the Medicare hospice benefit. Hospice J. 1999;14:1-12.
12. Ezekiel EJ, Ash A, Yu W, et al. Managed care, hospice use, site of death and medical expenditures in the last year of life. Arch Intern Med. 2002;162:1722-1728.
13. Christakis NA, Escarce JJ. Survival of Medicare patients after enrollment in hospice programs. N Engl J Med. 1996;353:172-178.
14. Virnig B A, Kind S, McBean M, et al. Geographic variation in hospice use prior to death. J Am Geriatr Soc. 2000;48:1117-1125.
15. Virnig BA, McBean AM, Kind S, et al. Hospice use before death: variability across cancer diagnoses. Med Care. 2002;40:73-78.
16. Ries LAG, Eisner MP, Kosary CL, et al., eds. SEER Cancer Statistics Review, 1973-1999. Bethesda, MD: National Cancer Institute; 2002. Available at: http://seer.cancer.gov/csr/1973_1999/. Accessed February 2003..
17. Potosky AL, Riley GF, Lubitz JD, et al. Potential for cancer related health services research using a linked Medicare-tumor registry data-base. Med Care. 1993;31:732-748.
18. Morgan RO, Virnig BA, DeVito CA, et al. The Medicare-HMO revolving door - the healthy go in and the sick go out. N Engl J Med. 1997;337:169-175.
19. Ruof J, Mittendorf T, Pirk O, et al. Diffusion of innovations: treatment of Alzheimer's disease in Germany. Health Policy. 2002;60:59-66.
20. Coleman RE. Current and future status of adjuvant therapy for breast cancer. Cancer. 2003;97:880-886.
21. Diaz-Coleman EA, Pazdur R. Adjuvant medical therapy for colorectal cancer. Surg Clin North Am. 1997;77:211-228.
22. Peschel RE, Colberg JW. Surgery, brachytherapy, and external-beam radiotherapy for early prostate cancer. Lancet Oncol. 2003;4:233-241.
23. Edwards BK, Howe HL, Ries LAG, et al. Annual report to the nation on the status of cancer, 1973-1999, featuring implications of age and aging on the US cancer burden. Cancer. 2002;94:2766-2792.
24. Warren JL, Klabunde CN, Sehrag D, et al. Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Med Care. 2002;40:IV-3-IV-18.
25. Crawley L, Payne R, Bolden J, et al. Palliative and end-of-life care in the African American community. JAMA. 2000;284:2518-2521.
26. Bass DM, Labus JG. Social determinants of the passage to hospice care. Social Focus. 1985;18:337-351.
27. Borum ML, Lynn J, Zhong Z. The effects of patient race on outcomes in seriously ill patients in SUPPORT: an overview of economic impact, medical intervention, and end-of-life decisions. J Am Geriatr Soc. 2000;S194-S198.
28. Crawley LM, Marshall PA, Bernard L, et al. Strategies for culturally effective end-of-life care. Ann Intern Med. 2002;136:673-679.
29. Hillman AL, Schwartz JS. The adoption and diffusion of CT and MRI in the United States. A comparative analysis. Med Care. 1985;23:1283-1294.